Exchange: NASDAQ·Updated 07:47 PM EDT
VRDN logo

VRDN Viridian Therapeutics Inc

$20.47
$0.19
(0.92%)
Today
Closed $20.47
$0.03
(0.15%)
After Hours
EarningsNov 5
Mkt Cap$2.32B
Vol2.09M

About VRDN

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.
40

Bearish Sentiment

How do you feel about VRDN?

VRDNBull
$VRDN Lily is acquiring a company with a similar research strategy as Veridian - Merida Biosciences - for a reported $2.9B. Merida's lead candidate is in phase 1, meaning years away from the market and success is not guaranteed. Merida will be a financial burden for several years and one could probably correctly assume that Merida has a lot of debt used to keep it moving forward. VRDN has an APPROVED drug in the market creating REVENUE, another less than a year way from probable APPROVAL, a robust pipeline, ZERO debt and $800M or so in cash (which is deducted from its market cap when determining an acquisition cost). How much should that be worth to an acquirer? I venture to say at least twice (2.5-3X?) what was paid for Merida now and more when the next approval is granted.
4
forprofit12
$VRDN I don’t like to use manipulation as a justification, but I fail to see any other reason why this is so undervalued.
3
forprofit12
$VRDN no good news moves this as the stock is highly manipulated. My best guess is like crnx it will get acquired. Just a guess and sp matches what was being done to crnx
1

Advertisement|Remove ads.